Newlin, William R.

Insider profile

Performance

Overall performance
1.9

Performance over holding periods
1.9
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
14 100% Buy
34 71% Buy
47 69% Buy
Newlin, William R.'s trades of Sharp Therapeutics Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-04 2025-11-03 B Purchase
84,747 -4.4%
78.27
US$4,700,063
84,747 -4.4% 78.27 US$4,700,063
2025-10-30 2025-10-29 B Purchase
19,099 -39.6%
279.76
US$4,017,982
19,099 -39.6% 279.76 US$4,017,982
2025-10-28 2025-10-27 B Purchase
76,460 +23.7%
223.03
US$4,090,622
76,460 +23.7% 223.03 US$4,090,622
2025-10-27 2025-10-24 B Purchase
500 +2.6%
2.61
US$1,305
500 +2.6% 2.61 US$1,305
2025-10-23 2025-10-22 B Purchase
3,800 +24.8%
2.61
US$9,918
3,800 +24.8% 2.61 US$9,918
2025-10-23 2025-10-21 B Purchase
3,400 +28.6%
2.61
US$8,874
3,400 +28.6% 2.61 US$8,874
2025-10-21 2025-10-20 B Purchase
200 +1.7%
2.61
US$522
200 +1.7% 2.61 US$522
2025-10-21 2025-10-20 B Purchase
200 +1.7%
2.56
US$512
200 +1.7% 2.56 US$512
2025-10-20 2025-10-17 B Purchase
2,100 +22.3%
2.55
US$5,355
2,100 +22.3% 2.55 US$5,355
2025-10-20 2025-10-17 B Purchase
300 +3.3%
2.55
US$765
300 +3.3% 2.55 US$765
2025-10-20 2025-10-16 B Purchase
300 +3.4%
2.11
US$633
300 +3.4% 2.11 US$633
2025-10-20 2025-10-16 B Purchase
200 +2.3%
2.10
US$420
200 +2.3% 2.10 US$420
2025-10-20 2025-10-16 B Purchase
2,900 +50.9%
2.11
US$6,119
2,900 +50.9% 2.11 US$6,119
2025-10-20 2025-10-16 B Purchase
100 +1.8%
1.90
US$190
100 +1.8% 1.90 US$190
2025-10-14 2025-10-10 B Purchase
1,500 +36.6%
1.60
US$2,400
1,500 +36.6% 1.60 US$2,400
2025-10-09 2025-10-08 B Purchase
1,000 +32.3%
1.40
US$1,400
1,000 +32.3% 1.40 US$1,400